ATE103980T1 - Das f-protein vom aids-virus enthaltender impfstoff. - Google Patents

Das f-protein vom aids-virus enthaltender impfstoff.

Info

Publication number
ATE103980T1
ATE103980T1 AT87401338T AT87401338T ATE103980T1 AT E103980 T1 ATE103980 T1 AT E103980T1 AT 87401338 T AT87401338 T AT 87401338T AT 87401338 T AT87401338 T AT 87401338T AT E103980 T1 ATE103980 T1 AT E103980T1
Authority
AT
Austria
Prior art keywords
protein
vaccine containing
aids virus
aids
virus
Prior art date
Application number
AT87401338T
Other languages
English (en)
Inventor
Marie-Paule Kieny
Bruno Guy
Jean-Pierre Lecocq
Luc Montagnier
Original Assignee
Transgene Sa
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa, Pasteur Institut filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE103980T1 publication Critical patent/ATE103980T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT87401338T 1986-06-16 1987-06-15 Das f-protein vom aids-virus enthaltender impfstoff. ATE103980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8608698A FR2600079B1 (fr) 1986-06-16 1986-06-16 Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
EP87401338A EP0253693B1 (de) 1986-06-16 1987-06-15 Das F-Protein vom AIDS-Virus enthaltender Impfstoff

Publications (1)

Publication Number Publication Date
ATE103980T1 true ATE103980T1 (de) 1994-04-15

Family

ID=9336386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401338T ATE103980T1 (de) 1986-06-16 1987-06-15 Das f-protein vom aids-virus enthaltender impfstoff.

Country Status (11)

Country Link
EP (1) EP0253693B1 (de)
JP (1) JPH01500962A (de)
KR (1) KR880701285A (de)
AT (1) ATE103980T1 (de)
AU (1) AU614934B2 (de)
DE (1) DE3789525T2 (de)
DK (1) DK76688A (de)
ES (1) ES2062990T3 (de)
FR (1) FR2600079B1 (de)
PT (1) PT85093B (de)
WO (1) WO1987007642A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615623B1 (fr) * 1987-05-22 1992-06-19 Transgene Sa Test de diagnostic du sida base sur la mise en evidence d'une diversite de la reponse isotypique, vaccins et serotherapies
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
FR2629459B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf11 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
JPH03503639A (ja) * 1988-04-01 1991-08-15 アンステイテユ・パストウール レトロウイルスｈｉｖのペプチドｐｆ１０〜ｐｆ１９、該ペプチドの合成方法、特に診断用としてのその使用
FR2629460B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf16 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation pour le diagnostic
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
ATE177786T1 (de) * 1990-05-28 1999-04-15 Univ Osaka Res Found Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt
FR2766091A1 (fr) 1997-07-18 1999-01-22 Transgene Sa Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee

Also Published As

Publication number Publication date
EP0253693A1 (de) 1988-01-20
FR2600079A1 (fr) 1987-12-18
DK76688D0 (da) 1988-02-15
FR2600079B1 (fr) 1989-10-20
AU7514087A (en) 1988-01-11
DE3789525D1 (de) 1994-05-11
WO1987007642A1 (fr) 1987-12-17
EP0253693B1 (de) 1994-04-06
DK76688A (da) 1988-02-15
AU614934B2 (en) 1991-09-19
PT85093A (fr) 1987-07-01
PT85093B (pt) 1990-03-30
DE3789525T2 (de) 1994-08-25
JPH01500962A (ja) 1989-04-06
ES2062990T3 (es) 1995-01-01
KR880701285A (ko) 1988-07-26

Similar Documents

Publication Publication Date Title
ES2194029T3 (es) Variantes del virus hiv-2.
DE3760912D1 (en) Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
EP0256092A4 (de) Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten.
DE3789973D1 (de) Zahnimplantat zur Befestigung von Zahnersatz-Suprakonstruktionen.
EP0179139A4 (de) Leukämieassoziiertes virusimmunogen, impfstoff und testverfahren.
DK573783A (da) Gen, dna eller en underenhed heraf, som koder for human h2-preprorelaxin eller en underenhed deraf, fremgangsmaade til fremstilling af samme samt fremgangsmaade til fremstilling af human h2-preprorelaxin eller en underenhed deraf
ATE237682T1 (de) Universale spenderzellen
HU9201746D0 (en) Recombinant avipox virus, the virus infected cell cultivation and the vaccine resulted from it for poultry vaccination
DE3789525D1 (de) Das F-Protein vom AIDS-Virus enthaltender Impfstoff.
NO883834L (no) Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
DK498387D0 (da) Virus-dna-sekvens
ATE124991T1 (de) Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine.
DE3767731D1 (de) Prostacyclinanalog, dieses als aktives bestandteil enthaltendes, den blutumlauf verbesserndes mittel und gegen magengeschwuere wirkendes mittel.
ATE103934T1 (de) Impfstoff bestehend aus einem virusvektor und rekombinanten-dns, die das p25-protein vom aids- virus kodieren.
DE3785804D1 (de) Komforme biomedizinische flachelektrode.
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
ATE84070T1 (de) Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen.
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
DE68925356D1 (de) Nicht-zurückmutierende RNA-Viren
NL300254I1 (nl) Verzwakte herpesvirussen, herpesvirussen die vreemd DNA omvatten dat codeert voor een aminozuur-sequentie en vaccin dat het bevat.
RU92016478A (ru) Способ диагностики гепатита, способ лечения гепатита
ATE98379T1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
NO884654D0 (no) Virusantigen, fremgangsmaate for dets fremstilling og anvendelse i diagnose og terapi (vaksine).